Sever Pharma Solutions, a provider of pharmaceutical CDMO services, has been granted approval by the Swedish health authorities for its aseptic filling line for syringes, specifically designed for high potent injectable drugs, at its Malmo site. 

The new aseptic filling line represents a substantial investment in advanced technology and infrastructure, and is equipped with the latest automated systems and quality control measures. By employing stringent aseptic techniques and advanced barrier systems, Sever Pharma Solutions guarantees the sterility and purity of the drugs being filled, maintaining their potency throughout the entire process.

Sever’s new aseptic filling line is specifically designed for syringes, providing a reliable and efficient solution for producing high potent injectable drugs. This advanced system enhances the company’s manufacturing capacity and allows for seamless integration with its assembly solutions for auto-injectors.

“We are thrilled to announce the approval of our new aseptic filling line for syringes, designed specifically for high potent injectable drugs,” said Kenneth Stokholm, CEO at Sever Pharma Solutions. “This investment showcases our commitment to innovation and our dedication to meeting the evolving needs of our clients in the pharmaceutical industry. Integrating our state-of-the-art assembly lines for auto-injectors further strengthens our position as a comprehensive solution provider, enabling us to deliver unparalleled quality and value.”